HPV legislation in Louisiana
Women in Government Ratings
Women in Government, a non-profit network of state level women legislators, receives significant funding from the pharmaceutical industry, including Merck, GlaxoSmithKline, and Digene Corporation -- all with products related to HPV vaccination and testing. According to their report, "The 'State' of Cervical Cancer Prevention in America - 2008" :
Incidence & Mortality (2008 Score / 2007 Score)
- Cervical Cancer Incidence Rate: 9.2/100,000 (1/ 1)
- Cervical Cancer Incidence Rate/Race: White: 7.9, Black: 13.1
- Cervical Cancer Mortality Rate: 2.9/100,000 (1 / 1)
- Cervical Cancer Mortality Rate/Race: White: 1.6, Black: 5.9
Screening (2008 Score / 2007 Score)
- Cervical Cancer Screening Rate: 84.5% (1 / 1)
- Cervical Cancer Screening Rate/Race: White: 85.3%, Black: 86.9%, Hispanic: 67.5%
- % Uninsured/Unscreened: 23.3% (1 / 1)
- Medicaid Coverage HPV Testing: Unrestricted (2 / 2)
Healthcare Access (2008 Score / 2007 Score)
- Rate Uninsured Women: 27% (0 / 0)
- % Low Income/Uninsured Women: 46%
Policy Initiatives and Infrastructure (2008 Score / Cumulative Score (2005–2008)
Screening Requirements (0 / 1)
- There are no new screening requirements.
Task Forces (0 / 1)
- There is no new cervical cancer prevention task force legislation.
Access to HPV Vaccines (0 / 0)
- There is no HPV vaccine activity.
HPV Vaccine Information Programs (0 / 0)
- There is no HPV vaccine information activity.
Miscellaneous (0 / 1)
- There is no new miscellaneous cervical cancer prevention activity.
- Public health units and some physicians and clinics have begun offering adolescent girls HPV vaccines at no cost through the state's Vaccines for Children Program. According to assistant state health officer Erin Brewer, Louisiana negotiated a discounted price of $96.75 per dose with Merck for Gardasil; the state has received 29,040 doses and an additional 19,300 have been ordered.
- 2008: Fair (9 out of 22 points)
- 2007: Good (9 out of 18 points)
Articles and resources
- Women in Government
- The Marketing of Gardasil in Australia
- The Marketing of Gardasil in Canada
- The Marketing of Gardasil in Europe
- The Marketing of Gardasil in New Zealand
- The Marketing of Gardasil in the United States
- Direct-to-consumer advertising
- Disease Mongering
- Drug industry
- Judith Siers-Poisson, The Politics and PR of Cervical Cancer, a four part series, PRWatch.org, July, 2007.
- "The 'State' of Cervical Cancer Prevention in America - 2008", Women in Government